Found: 60
Select item for more details and to access through your institution.
Adaptation and validation of the memorial anxiety scale for prostate cancer (MAX-PC) in a sample of French men.
- Published in:
- Journal of Patient-Reported Outcomes, 2019, v. 3, n. 1, p. N.PAG, doi. 10.1186/s41687-019-0150-1
- By:
- Publication type:
- Article
Impact of active surveillance for prostate cancer on the risk of depression and anxiety.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-17224-w
- By:
- Publication type:
- Article
The use of estramustine phosphate in the modern management of advanced prostate cancer.
- Published in:
- BJU International, 2011, v. 108, n. 11, p. 1782, doi. 10.1111/j.1464-410X.2011.10201.x
- By:
- Publication type:
- Article
Docetaxel reintroduction in patients with metastatic castration-resistant docetaxel-sensitive prostate cancer: a retrospective multicentre study.
- Published in:
- BJU International, 2010, v. 106, n. 7, p. 974, doi. 10.1111/j.1464-410X.2010.09296.x
- By:
- Publication type:
- Article
Abigene, a Prospective, Multicentric Study of Abiraterone Acetate Pharmacogenetics in Metastatic Castration-Resistant Prostate Cancer †.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 2, p. 651, doi. 10.3390/pharmaceutics15020651
- By:
- Publication type:
- Article
Impact of First Line Antiangiogenic Therapy Duration on Nivolumab Outcome in Metastatic Renal Cell Carcinoma Patients Treated in the GETUG--AFU 26 NIVOREN.
- Published in:
- Clinical Genitourinary Cancer, 2023, v. 21, n. 6, p. 643, doi. 10.1016/j.clgc.2023.07.008
- By:
- Publication type:
- Article
Very Long-Term Complete Remission Can Be Achieved in Men With High-Risk Localized Prostate Cancer and a Very High PSA Value: An Analysis of the GETUG 12 Phase 3 Trial.
- Published in:
- Clinical Genitourinary Cancer, 2023, v. 21, n. 5, p. 615e1, doi. 10.1016/j.clgc.2023.05.003
- By:
- Publication type:
- Article
Real-World Treatment Patterns Among French Patients With Metastatic Castration-Resistant Prostate Cancer Under Abiraterone or Enzalutamide.
- Published in:
- Clinical Genitourinary Cancer, 2023, v. 21, n. 5, p. e362, doi. 10.1016/j.clgc.2023.04.004
- By:
- Publication type:
- Article
Efficacy and Safety of Concomitant Proton Pump Inhibitor and Nivolumab in Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study.
- Published in:
- Clinical Genitourinary Cancer, 2022, v. 20, n. 5, p. 488, doi. 10.1016/j.clgc.2022.07.003
- By:
- Publication type:
- Article
Comparison Between Micro-Ultrasound and Multiparametric MRI Regarding the Correct Identification of Prostate Cancer Lesions.
- Published in:
- Clinical Genitourinary Cancer, 2022, v. 20, n. 4, p. e339, doi. 10.1016/j.clgc.2022.01.013
- By:
- Publication type:
- Article
Chemotherapy for Muscle-invasive Bladder Cancer: Impact of Cisplatin Delivery on Renal Function and Local Control Rate in the Randomized Phase III VESPER (GETUG-AFU V05) Trial.
- Published in:
- Clinical Genitourinary Cancer, 2021, v. 19, n. 6, p. 554, doi. 10.1016/j.clgc.2021.08.005
- By:
- Publication type:
- Article
Cost-effectiveness Analysis of Innovative Therapy for Patients with Newly Diagnosed Hormone-Sensitive Metastatic Prostate Cancer.
- Published in:
- Clinical Genitourinary Cancer, 2021, v. 19, n. 5, p. e326, doi. 10.1016/j.clgc.2021.03.022
- By:
- Publication type:
- Article
Prognostic Risk Classification for Biochemical Relapse-Free Survival in Oligometastatic Recurrent Prostate Cancer Determined by Choline PET.
- Published in:
- Clinical Genitourinary Cancer, 2021, v. 19, n. 4, p. 346, doi. 10.1016/j.clgc.2021.03.004
- By:
- Publication type:
- Article
Immunothérapies dans le cancer de la prostate : contourner l'immunosuppression pour traiter le cancer.
- Published in:
- Revue Immunité & Cancer, 2023, v. 7, n. 4, p. 175
- By:
- Publication type:
- Article
Durable disease control and refractory bullous pemphigoid after immune checkpoint inhibitor discontinuation in metastatic renal cell carcinoma: A case report.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.984132
- By:
- Publication type:
- Article
Pharmacokinetic and Pharmacogenetic Study of Etoposide in High-Dose Protocol (TI-CE) for Advanced Germ Cell Tumors.
- Published in:
- Pharmaceutical Research, 2020, v. 37, n. 7, p. 1, doi. 10.1007/s11095-020-02861-5
- By:
- Publication type:
- Article
Langfristige Vollremission mit Ipilimumab bei metastasiertem kastrationsresistentem Prostatakrebs: Fallbericht von zwei Patienten.
- Published in:
- 2018
- By:
- Publication type:
- Other
Metastatic hormone sensitive prostate cancer: local treatment strategies.
- Published in:
- World Journal of Urology, 2021, v. 39, n. 2, p. 327, doi. 10.1007/s00345-020-03296-8
- By:
- Publication type:
- Article
External validation of the Heidenreich criteria for patient selection for unilateral or bilateral retroperitoneal lymph node dissection for post-chemotherapy residual masses of testicular cancer.
- Published in:
- World Journal of Urology, 2014, v. 32, n. 6, p. 1573, doi. 10.1007/s00345-014-1240-6
- By:
- Publication type:
- Article
Comparison of image-guided targeted biopsies versus systematic randomized biopsies in the detection of prostate cancer: a systematic literature review of well-designed studies.
- Published in:
- World Journal of Urology, 2014, v. 32, n. 4, p. 847, doi. 10.1007/s00345-014-1332-3
- By:
- Publication type:
- Article
Identification of the prostate cancer index lesion by real-time elastography: considerations for focal therapy of prostate cancer.
- Published in:
- World Journal of Urology, 2011, v. 29, n. 5, p. 589, doi. 10.1007/s00345-011-0688-x
- By:
- Publication type:
- Article
Refining the Characterization and Outcome of Pathological Complete Responders after Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Lessons from the Randomized Phase III VESPER (GETUG-AFU V05) Trial.
- Published in:
- Cancers, 2023, v. 15, n. 6, p. 1742, doi. 10.3390/cancers15061742
- By:
- Publication type:
- Article
Is CIS a Contraindication to Hyperthermic Intravesical Chemotherapy (HIVEC) after BCG-Failure?
- Published in:
- Cancers, 2023, v. 15, n. 5, p. 1455, doi. 10.3390/cancers15051455
- By:
- Publication type:
- Article
Molecular Profiles of Advanced Urological Cancers in the PERMED-01 Precision Medicine Clinical Trial.
- Published in:
- Cancers, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/cancers14092275
- By:
- Publication type:
- Article
The Psychological Distress of Cancer Patients following the COVID-19 Pandemic First Lockdown: Results from a Large French Survey.
- Published in:
- Cancers, 2022, v. 14, n. 7, p. 1794, doi. 10.3390/cancers14071794
- By:
- Publication type:
- Article
Endoscopic Ultrasound-Guided Radiofrequency Ablation as an Future Alternative to Pancreatectomy for Pancreatic Metastases from Renal Cell Carcinoma: A Prospective Study.
- Published in:
- Cancers, 2021, v. 13, n. 21, p. 5267, doi. 10.3390/cancers13215267
- By:
- Publication type:
- Article
Advance Approval of Outpatient Chemotherapy via Phone Call Optimizes Healthcare Delivery without Compromising Patient Satisfaction with Care.
- Published in:
- Cancers, 2021, v. 13, n. 6, p. 1337, doi. 10.3390/cancers13061337
- By:
- Publication type:
- Article
Deterioration of Sexual Health in Cancer Survivors Five Years after Diagnosis: Data from the French National Prospective VICAN Survey.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3453, doi. 10.3390/cancers12113453
- By:
- Publication type:
- Article
Concomitant chemoradiotherapy for patients with nonmetastatic breast carcinoma.
- Published in:
- Cancer (0008543X), 1999, v. 85, n. 10, p. 2190, doi. 10.1002/(SICI)1097-0142(19990515)85:10<2190::AID-CNCR13>3.0.CO;2-P
- By:
- Publication type:
- Article
Major response with sorafenib in advanced renal cell carcinoma after 14 years of follow-up.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
A non-inferiority randomized phase III trial of standard immunotherapy by checkpoint inhibitors vs. reduced dose intensity in responding patients with metastatic cancer: the MOIO protocol study.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10881-8
- By:
- Publication type:
- Article
Multicentric phase II trial of TI‐CE high‐dose chemotherapy with therapeutic drug monitoring of carboplatin in patients with relapsed advanced germ cell tumors.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 7, p. 2250, doi. 10.1002/cam4.3687
- By:
- Publication type:
- Article
Corrigendum: Gastrointestinal Metastases From Primary Renal Cell Cancer: A Single Center Review.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Gastrointestinal Metastases From Primary Renal Cell Cancer: A Single Center Review.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.644301
- By:
- Publication type:
- Article
Cabozantinib‐nivolumab sequence in metastatic renal cell carcinoma: The CABIR study.
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 8, p. 1335, doi. 10.1002/ijc.34126
- By:
- Publication type:
- Article
Weekly administration of docetaxel for symptomatic metastatic hormone-refractory prostate carcinoma.
- Published in:
- Cancer (0008543X), 2003, v. 98, n. 8, p. 1627, doi. 10.1002/cncr.11687
- By:
- Publication type:
- Article
Radiation therapy following targeted therapy in oligometastatic renal cell carcinoma.
- Published in:
- Molecular & Clinical Oncology, 2015, v. 3, n. 6, p. 1248, doi. 10.3892/mco.2015.613
- By:
- Publication type:
- Article
Soluble BTN2A1 Is a Potential Prognosis Biomarker in Pre-Treated Advanced Renal Cell Carcinoma.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2021.670827
- By:
- Publication type:
- Article
A serum metabolomic fingerprint of bevacizumab and temsirolimus combination as first-line treatment of metastatic renal cell carcinoma.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Long-term efficacy of crizotinib in a metastatic papillary renal carcinoma with MET amplification: a case report and literature review.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Is negative multiparametric magnetic resonance imaging really able to exclude significant prostate cancer? The real-life experience.
- Published in:
- BJU International, 2017, v. 119, n. 3, p. 449, doi. 10.1111/bju.13657
- By:
- Publication type:
- Article
Intermediate analysis of a phase II trial assessing gemcitabine and cisplatin in locoregional or metastatic penile squamous cell carcinoma.
- Published in:
- BJU International, 2016, v. 117, n. 3, p. 444, doi. 10.1111/bju.13054
- By:
- Publication type:
- Article
Efficacy and tolerance of hyperthermic intravesical chemotherapy (HIVEC) according to the number of instillations administered.
- Published in:
- World Journal of Urology, 2024, v. 42, n. 1, p. 1, doi. 10.1007/s00345-024-05219-3
- By:
- Publication type:
- Article
Multiparametric Magnetic Resonance Imaging in the follow-up of non-muscle-invasive bladder tumors after intravesical instillations: a promising tool.
- Published in:
- World Journal of Urology, 2024, v. 42, n. 1, p. 1, doi. 10.1007/s00345-024-04868-8
- By:
- Publication type:
- Article
Efficacy of hyperthermic intravesical chemotherapy (HIVEC) in patients with non-muscle invasive bladder cancer after BCG failure.
- Published in:
- World Journal of Urology, 2023, v. 41, n. 11, p. 3195, doi. 10.1007/s00345-023-04332-z
- By:
- Publication type:
- Article
External validation of the computerized analysis of TRUS of the prostate with the ANNA/C-TRUS system: a potential role of artificial intelligence for improving prostate cancer detection.
- Published in:
- World Journal of Urology, 2023, v. 41, n. 3, p. 619, doi. 10.1007/s00345-022-03965-w
- By:
- Publication type:
- Article
Enhanced Recovery after Surgery for Radical Cystectomy Decreases Postoperative Complications at Different Times.
- Published in:
- Urologia Internationalis, 2022, v. 106, n. 2, p. 171, doi. 10.1159/000518163
- By:
- Publication type:
- Article
VEGFR1 single nucleotide polymorphisms associated with outcome in patients with metastatic renal cell carcinoma treated with sunitinib - a multicentric retrospective analysis.
- Published in:
- Acta Oncologica, 2014, v. 53, n. 1, p. 103, doi. 10.3109/0284186X.2013.770600
- By:
- Publication type:
- Article
Full access to medical records does not modify anxiety in cancer patients: Results of a randomized study.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Full access to medical records does not modify anxiety in cancer patients.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 20, p. 4796, doi. 10.1002/cncr.26083
- By:
- Publication type:
- Article